Neuromod raises $6.2m in Series A

Neuromod said today it raised $6.2 million (EU€5.5 million) in a Series A round of financing, with fund slated to support its mutebutton bi-modal neuromodulation device for patients with chronic tinnitus. Funds from the round came from venture capital firm Fountain Healthcare Partners, the Dublin-based company said. “Neuromod is delighted to announce this investment, which will help us to advance our unique chronic tinnitus treatment technology. As an emerging company we welcome the support and knowledge offered to us from partnering with an experienced international life sciences venture capital fund such as Fountain Healthcare Partners. We are also particularly grateful for the ongoing support we have received from our manufacturing partners, M&M Qualtech and Molex, and from Enterprise Ireland, which enable innovative Irish companies, like Neuromod, to grow and succeed on the international stage,” CEO Dr Ross O’Neill said in prepared remarks. The mutebutton is a handheld bi-modal neuromodulation device device that helps the brain distinguish between real and phantom noises through audio and tongue stimulation. The system promotes neur0plasticity in areas of the brain associated with tinnitus, the company said. “Neuromod is an exciting company, with the potential to offer a superior treatment to and improve the quality of life of the millions of patients suffering with chronic tinnitus. The company has a proprietary neuromodulation tech...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Clinical Trials Neuromodulation/Neurostimulation Neuromod Devices Source Type: news

Related Links:

Publication date: September–October 2018Source: Brain Stimulation, Volume 11, Issue 5Author(s): Samer Mohsen, Saeid Mahmoudian, Saeed Talebian, Akram Pourbakht
Source: Brain Stimulation - Category: Neurology Source Type: research
Conclusion: the hearing protector was worn by 59.7% of the workers, the plug model was the most used (47.4%) and 75.8% reported that occupational noise decreased with the use of hearing protectors. Most workers use hearing protection and have no hearing symptoms. However, the presence of symptoms such as otalgia (8.8%), otorrhea (5.3%), dizziness (14.0%), tinnitus (17.5%) and difficulty in speech comprehension (7, 0%) should be pointed out. Noise assessment showed high levels from some maintenance machinery, representing a risk for hearing. The sectors of the woodwork and metalwork were the noisiest.RESUMO Objetivo: invest...
Source: Revista CEFAC - Category: Speech-Language Pathology Source Type: research
Condition:   Focus of the Study is the Comparison of the TFI Value of the Two German Versions Intervention:   Other: No intervention planned Sponsor:   University of Zurich Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Journal of Oral Rehabilitation,Volume 0, Issue ja, -Not available-.
Source: Journal of Oral Rehabilitation - Category: Dentistry Authors: Source Type: research
Journal of Oral Rehabilitation,Volume 0, Issue ja, -Not available-.
Source: Journal of Oral Rehabilitation - Category: Dentistry Authors: Source Type: research
Publication date: Available online 17 August 2018Source: British Journal of Oral and Maxillofacial SurgeryAuthor(s): L.F.O. Maciel, F.S. Landim, B.C. VasconcelosAbstractIn a prospective, observational study between April and November 2017 we evaluated the correlation between temporomandibular disorder (TMD), and otological signs and other symptoms in a sample of 251 patients. First, a simplified anamnestic questionnaire was applied for the diagnosis of TMD and the following symptoms were recorded: otalgia, tinnitus, vertigo, pruritus of the ear, feeling of hearing loss, fullness in the ear, headache, pain in the eye, neck ...
Source: British Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Source Type: research
Sudden sensorineural hearing loss (SSNHL) is defined as a hearing loss of 30 dBHL or more in three consecutive frequency ranges within 72  hours as measured by pure tone audiometry [1,2]. The prevalence of SSNHL varies by region with an estimated worldwide prevalence of 5~20 cases/100,000 people [3]. Unilateral hearing loss, tinnitus, aural fullness, and vertigo are the most common symptoms of SSNHL [4]. SSNHL with these symptoms ca n have a devastating effect on quality of life and social functions, which suggests that a multidisciplinary (psychological, social, and medical) approach should be undertaken for these patients [5].
Source: Patient Education and Counseling - Category: International Medicine & Public Health Authors: Source Type: research
Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulation treatment that involves the induction of electrical currents in a targeted region of the brain with the ability to impact various functional processes (Chervyakov  et al., 2015). rTMS has shown to provide clinical improvement among a variety of neurological and psychiatric disorders and has been FDA-approved for treatment resistant depression (TRD). rTMS continues to undergo trials for other treatment indications including post-traumatic stress disorder (PT SD), generalized anxiety disorder (GAD), bipolar depression, schizophren...
Source: Journal of Affective Disorders - Category: Neurology Authors: Tags: Research paper Source Type: research
DISCUSSION: A large percentage of workers exposed to noisy workplaces were vulnerable because hearing protection was neither required nor routinely used. Further work is required to assess whether this reflects gaps in health and safety legislation or its implementation. PMID: 30110508 [PubMed - in process]
Source: Health Reports - Category: International Medicine & Public Health Tags: Health Rep Source Type: research
CONCLUSIONS In this retrospective review, sectioning of the NI produced no major complications, such as permanent facial weakness or deafness, and was effective for patients when performed in addition to other procedures. After sectioning of the NI, patients experienced 4.8 years pain free and experienced 6.2 years of less pain than before surgery. Alone, sectioning of the NI was not effective. The pathophysiology of NIN is not entirely understood. It appears that neurovascular compression plays only a minor role in the syndrome and there is a high degree of overlap with TN. PMID: 30117769 [PubMed - as supplied by publisher]
Source: Journal of Neurosurgery - Category: Neurosurgery Authors: Tags: J Neurosurg Source Type: research
More News: Brain | Clinical Trials | Medical Devices | Neurology | Tinnitus | Venture Capital